Hybrid FSP/FSO Partnerships: A Bespoke Outsourcing Strategy to Maximize Clinical Development Efficiency
As clinical trials grow in complexity, outsourcing has become essential and can be employed in a variety of models to fit specific research needs.
Traditionally, the most common outsourcing arrangements are functional service provider (FSP) partnerships and full-service outsourcing (FSO). However, sponsors are increasingly adopting a hybrid outsourcing model where FSP partnerships augment FSO arrangements. This maximizes clinical development speed and efficiency and helps biopharmaceutical and biotech companies meet their timelines.
In this webinar, discover how PPD™ Functional Service Partnership (FSP) solutions experts are enabling hybrid outsourcing models that help biopharma and biotech companies:
- Enhance agility and flexibility to optimize clinical trial operations
- Address unanticipated or changing demands
- Maximize clinical trial performance
- Overcome persistent challenges in clinical trial operations
